AMIH Majority Owned Subsidiary, EPIQ Scripts, Obtains Controlled Substance Registration from the U.S. Department of Justice & Drug Enforcement Administration (DEA)
01. Dezember 2022 10:30 ET
|
American International Holdings Corp.
EPIQ Scripts has also submitted applications for various nationally recognized accreditation agencies and associations Dallas, Texas, Dec. 01, 2022 (GLOBE NEWSWIRE) -- American International...
CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
12. März 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement...
CURE Pharmaceutical Secures U.S. DEA Approval to Manufacture Cannabinoid-based Pharmaceuticals
26. November 2018 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has secured a new registration with the...